Privia Health Group (NASDAQ:PRVA) Director Matthew Shawn Morris Sells 53,722 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVA) Director Matthew Shawn Morris sold 53,722 shares of the business’s stock in a transaction on Monday, July 6th. The stock was sold at an average price of $27.24, for a total value of $1,463,387.28. Following the completion of the transaction, the director directly owned 68,188 shares in the company, valued at approximately $1,857,441.12. This represents a 44.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Shawn Morris also recently made the following trade(s):

• On Thursday, July 2nd, Matthew Shawn Morris sold 59,037 shares of Privia Health Group stock. The shares were sold at an average price of $27.33, for a total value of $1,613,481.21.
• On Monday, June 29th, Matthew Shawn Morris sold 63,212 shares of Privia Health Group stock. The stock was sold at an average price of $25.33, for a total transaction of $1,601,159.96.
• On Friday, June 26th, Matthew Shawn Morris sold 88,110 shares of Privia Health Group stock. The stock was sold at an average price of $25.33, for a total transaction of $2,231,826.30.
• On Friday, May 1st, Matthew Shawn Morris sold 17,096 shares of Privia Health Group stock. The shares were sold at an average price of $24.99, for a total transaction of $427,229.04.
• On Monday, May 4th, Matthew Shawn Morris sold 1,017 shares of Privia Health Group stock. The shares were sold at an average price of $24.96, for a total transaction of $25,384.32.

Privia Health Group Trading Up 0.1%

Shares of NASDAQ:PRVA traded up $0.04 during mid-day trading on Tuesday, reaching $27.23. The company had a trading volume of 1,077,240 shares, compared to its average volume of 934,312. The firm has a market cap of $3.43 billion, a price-to-earnings ratio of 170.20, a PEG ratio of 2.16 and a beta of 0.83. The company’s 50-day moving average price is $23.53 and its 200-day moving average price is $23.04. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $27.70.

Analysts Set New Price Targets

PRVA has been the subject of several recent research reports. Canaccord Genuity Group decreased their price objective on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a report on Friday, May 8th. Evercore set a $26.00 price target on shares of Privia Health Group in a research report on Wednesday, April 8th. Weiss Ratings raised shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday. Finally, Barclays reduced their price objective on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $31.15.

Hedge Funds Weigh In On Privia Health Group

Large investors have recently modified their holdings of the company. Durable Capital Partners LP increased its holdings in Privia Health Group by 1.8% during the 3rd quarter. Durable Capital Partners LP now owns 11,691,685 shares of the company’s stock worth $291,123,000 after acquiring an additional 203,842 shares during the period. State Street Corp increased its holdings in shares of Privia Health Group by 1.5% in the second quarter. State Street Corp now owns 4,171,069 shares of the company’s stock worth $95,935,000 after purchasing an additional 61,853 shares during the period. Van Berkom & Associates Inc. increased its holdings in shares of Privia Health Group by 5.4% in the first quarter. Van Berkom & Associates Inc. now owns 4,053,043 shares of the company’s stock worth $83,371,000 after purchasing an additional 208,787 shares during the period. Geode Capital Management LLC raised its position in shares of Privia Health Group by 1.1% in the fourth quarter. Geode Capital Management LLC now owns 2,814,290 shares of the company’s stock worth $66,738,000 after buying an additional 31,204 shares in the last quarter. Finally, Principal Financial Group Inc. raised its position in shares of Privia Health Group by 1.6% in the fourth quarter. Principal Financial Group Inc. now owns 2,787,802 shares of the company’s stock worth $66,099,000 after buying an additional 43,589 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.